See also this year's filing and all EDGAR filings for this company.
PDF Report 0001626878_2023_XBiotech_Inc.pdf
Logs
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001626878, XBiotech Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 219,843,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 26,260,000 |
| 3 | remainder_Assets | 0 |
| 4 | LiabilitiesCurrent | 4,066,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 1,635,000 |
| 7 | CostOfGoodsAndServicesSold | 651,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 6,305,000 |
| 9 | ResearchAndDevelopmentExpense | 31,544,000 |
| 10 | remainder_Expenses | -688,000 |
| 11 | remainder_Revenues | 4,010,000 |
| 12 | remainder_NetIncome | 902,000 |
| 13 | remainder_ComprehensiveNetIncome | -1,145,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 246,103,000 |
| 1 | Liabilities | 5,701,000 |
| 2 | Expenses | 37,812,000 |
| 3 | Revenues | 4,010,000 |
| 4 | StockholdersEquity | 240,402,000 |
| 5 | NetIncome | -32,900,000 |
| 6 | ComprehensiveNetIncome | -33,472,500 |
| 7 | BaseVar | 147,836,500 |
| 8 | EconomicCapitalRatio | 3.02 |